2021-01-11,Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual Conference
2020-12-15,Immuron SARS-CoV-2 Research Agreement with Monash University
2020-11-24,"Immuron Receives AUD $358,280 R&D Tax Concession Refund"
2020-11-11,US DoD Naval Medical Research Center Reports Positive Immunological Responses to Vaccine
2020-10-12,Immuron Travelers Diarrhea Market Update
2020-07-23,Immuron Limited Announces Closing of $20.0 Million Registered Direct Offering
2020-07-22,"Introducing Immuron (ASX:IMC), The Stock That Soared 387% In The Last Year"
2020-07-21,Immuron's stock pulls back but still nearly doubles after stock offering
2020-07-21,Immuron Announces $20.0 Million Registered Direct Offering
2020-07-21,Immuron Reports Neutralizing Activity Against SARS-CoV-2 Key Points
2020-07-20,US DoD Naval Medical Research Center Receives FDA Guidance on the clinical development plans for new oral therapeutic
2020-06-19,Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense
2020-06-15,Price Over Earnings Overview: Immuron
2020-06-10,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset"
2020-06-09,"Nano-Cap Drugmaker Surges 1,000% as Retail Enthusiasm Spreads"
2020-06-09,Immuron's stock blasts off nearly 10-fold after partner NMRC seeks pre-IND meeting with FDA
2020-06-09,US DoD Naval Medical Research Center Requests Meeting with FDA for Guidance on two Phase 2 trials to Prevent Acute Infectious Diarrhea
2020-04-28,Immuron Board Relinquish Cash Payment of Fees
2020-04-20,"Immuron North American Travelan® Sales Up 95%, Global Sales Up 60%"
2020-03-25,"The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down"
2020-03-25,Resignation of CEO & Director and cost cutting amidst COVID-19
2020-03-18,Is Immuron (ASX:IMC) In A Good Position To Invest In Growth?
2020-03-03,Immuron Provides Update on First Half of FY20 Results
2020-02-03,Immurons Technology Platform of Treatments in the Age of the Coronavirus Outbreak
2020-01-28,North American Travelan® sales up 98% in the first half of FY20
2020-01-08,"Immuron CEO Dr. Gary S. Jacob to Present at Biotech Showcase Conference on January 13, 2020"
2019-11-21,Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers Diarrhea
2019-11-13,Could Immuron Limited's (ASX:IMC) Investor Composition Influence The Stock Price?
2019-11-04,Immuron Receives AUD $0.53M R&D Tax Concession Refund
2019-10-14,"A Look At Benzinga Pro's Most-Searched Tickers For October 14, 2019"
2019-10-14,Immuron North American Q1 Sales Up 111% YoY
2019-10-03,"A Look At Benzinga Pro's Most-Searched Tickers For October 3, 2019"
2019-10-02,"A Look At Benzinga Pro's Most-Searched Tickers For October 2, 2019"
2019-10-02,Immuron Receives $3.7M In Federal Dollars For Traveler's Diarrhea Preventative Therapy Project
2019-10-02,New U.S. Department of Defense Research Collaboration with Immuron to Develop and Clinically evaluate a New Therapeutic against Campylobacter
2019-09-24,Should You Be Concerned About Immuron Limited's (ASX:IMC) Historical Volatility?
2019-09-04,U.S. Defense Reports Immurons Travelan® demonstrates broad reactivity to Vibrio cholera strains from Southeast Asia indicating broad potential for prevention of travelers diarrhea
2019-08-16,Immuron to Commence Non-Deal Investor Roadshow
2019-08-12,BriaCell Appoints Richard J. Berman to Board of Directors
2019-08-08,Some Immuron (ASX:IMC) Shareholders Have Copped A Big 67% Share Price Drop
2019-08-08,Immuron Reports Results in Severe Alcoholic Hepatitis Clinical Trial
2019-07-17,"A Look At Benzinga Pro's Most-Searched Tickers For July 17, 2019"
2019-07-17,Immuron to Host Investor Webinar on July 18 to Provide Update on Recent Developments
2019-07-17,Immuron Prices Underwritten Public Offering of ADSs
2019-07-16,Immuron Announces Proposed Public Offering of ADSs
2019-07-16,"A Look At Benzinga Pro's Most-Searched Tickers For July 16, 2019"
2019-07-16,Immuron North American revenue surges by 52% in FY19
2019-06-25,Immuron Directors Increase Shareholdings in the Company
2019-06-19,Immuron to Commence US Non-Deal Institutional Investor Roadshow
2019-06-12,Immuron Rips Higher On Positive Preclinical Results For Travelan
2019-06-12,US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study
2019-06-07,How Much Are Immuron Limited (ASX:IMC) Insiders Spending On Buying Shares?
2019-05-30,Immuron Announces the Closing of Public Offering of ADSs
2019-05-23,Immuron Prices Underwritten Public Offering of ADSs
2019-05-23,Immuron Announces Proposed Public Offering of ADSs
2019-04-30,"Immuron CEO Dr. Gary S. Jacob to Present at the ThinkEquity Conference on May 2, 2019"
2019-04-17,Immuron Appoints CEO Dr. Gary S. Jacob to Board of Directors
2019-04-15,Do Institutions Own Immuron Limited (ASX:IMC) Shares?
2019-04-15,Immuron sales surge by 66% in the Third Quarter of FY19
2019-04-11,Immuron Receives U.S. Patent on Drug Composition to Treat Clostridium difficile
2019-04-11,Immuron Aims to Secure FDA Approval for IMM-124E to Prevent Travelers Diarrhea
2019-02-11,What You Must Know About Immuron Limiteds (ASX:IMC) Financial Strength
2019-01-29,Travelan® FY19 1st Half Update and Geographic Expansion into North America
2019-01-08,Immuron Receives $1.19M R&D Tax Concession Refund
2018-11-26,One Thing To Remember About The Immuron Limited (ASX:IMC) Share Price
2018-11-19,"Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO"
2018-11-09,NASH clinical trial presentation and continued revenue growth
2018-09-24,Could Immuron Limiteds (ASX:IMC) Investor Composition Impacts Your Returns?
2018-09-05,US Department of Defense Reports Travelan Protects Against Shigella in Primates
2018-07-25,Immuron Reports Record Revenue Exceeding AU$2 million for the FY18 year
2018-07-24,Immuron Announces it has Received a European Patent Grant for NASH treatment
2018-07-24,US Department of Defense Research Collaboration Moves Forward
2018-06-25,Immuron Announces Board Appointment
2018-05-07,Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program
2018-04-23,Immuron CEO to Present at RedChip Global Online Growth Conference
2018-04-23,Immurons Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets
2018-03-13,Immuron Announces A$5.1M Private Placement to U.S. Fund
2018-03-13,Immuron Progresses Discussions with Institutional Funds
2018-03-13,UPDATE -- Immuron Commences US Non-Deal Institutional Investor Roadshow
2018-03-12,Immuron Commences US Non-Deal Institutional Investor Roadshow
2018-03-07,Immuron Reports Positive Results in NASH Clinical Trial
2018-03-07,Immuron Limited Issues Correction to Misleading Halt Announcement Headline
2018-02-16,Travelan® Revenue Grows Significantly in US and Australia
2018-01-31,Immuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)
2018-01-29,US Defense Reports Broad Travelan® Reactivity to 180 Pathogenic Bacteria Including Camylobacter and Shigella
2018-01-24,Immuron to Receive $2.16M R&D Tax Concession Refund
